| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |